Octagon Capital Advisors LP Gossamer Bio, Inc. Transaction History
Octagon Capital Advisors LP
- $414 Million
- Q3 2024
A detailed history of Octagon Capital Advisors LP transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Octagon Capital Advisors LP holds 9,187,883 shares of GOSS stock, worth $7.72 Million. This represents 2.2% of its overall portfolio holdings.
Number of Shares
9,187,883
Previous 9,187,883
-0.0%
Holding current value
$7.72 Million
Previous $8.27 Million
10.0%
% of portfolio
2.2%
Previous 1.91%
Shares
8 transactions
Others Institutions Holding GOSS
# of Institutions
108Shares Held
167MCall Options Held
430KPut Options Held
519K-
Nea Management Company, LLC Timonium, MD18.1MShares$15.2 Million1.37% of portfolio
-
Siren, L.L.C. New York, NY13.3MShares$11.2 Million0.65% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$9.87 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$6.77 Million4.79% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.43MShares$5.4 Million0.0% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $78.9M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...